Akttyva Therapeutics is developing drugs that regulate the vascular permeability barrier, which is disrupted in >60 acute and chronic conditions. We target a key stress response pathway that restores the vascular barrier integrity using proprietary AI-assisted ML drug discovery platform. Akttyva's most advanced program is ARDS drug, with is 12 months from IND and we are looking for partnerships to develop drugs for other diseases based on this platform.
Connect with Akttyva Therapeutics
